Secondary
RA Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases.
Symbol
RARX
Last Closing Price
$6.71
Effective Date
February 27, 2018
Underwriters
Morgan Stanley
To view the prospectus for RA Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277